Rafael Holdings, Inc. RFL Infusion Technology — Operating Income
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Rafael Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The official record: Rafael Holdings, Inc.’s 10-Q, filed June 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Rafael Holdings, Inc.'s infusion technology — operating income.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Rafael Holdings, Inc.'s infusion technology — operating income?
- Rafael Holdings, Inc. (RFL) reported infusion technology — operating income of -$8K in Q1 2026.
- How has Rafael Holdings, Inc.'s infusion technology — operating income changed year-over-year?
- Rafael Holdings, Inc.'s infusion technology — operating income increased by 86.7% year-over-year, from -$60K to -$8K.
- What does infusion technology — operating income mean?
- Measures the profitability of the Infusion Technology segment by subtracting operating expenses from segment revenues. It provides a clear view of the segment's ability to generate earnings from its core business activities before interest and taxes. A loss indicates that the segment's operational costs currently exceed its revenue generation capacity.